NBSE - NeuBase Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
9/30/2022
9/30/2021
9/30/2020
9/30/2019
Total Revenue
0
0
0
0
0
Operating Expense
29,961
33,318
26,565
17,069
26,336
Operating Income
-29,961
-33,318
-26,565
-17,069
-26,336
Net Non Operating Interest Income Expense
284.21
124.509
-19.78
-7.686
-128.951
Other Income Expense
-739.692
-582.62
1,176
-307.528
-492.889
Pretax Income
-30,417
-33,776
-25,409
-17,385
-26,958
Net Income Common Stockholders
-30,417
-33,776
-25,409
-17,385
-26,958
Diluted NI Available to Com Stockholders
-30,417
-33,776
-25,409
-17,385
-26,958
Basic EPS
-
-1.04
-0.93
-0.89
-3.16
Diluted EPS
-
-1.04
-0.93
-0.89
-3.16
Basic Average Shares
-
32,487
27,306
19,620
8,272
Diluted Average Shares
-
32,487
27,306
19,620
8,272
Total Operating Income as Reported
-30,614
-33,318
-26,565
-17,069
-26,336
Total Expenses
29,961
33,318
26,565
17,069
26,336
Net Income from Continuing & Discontinued Operation
-30,417
-33,776
-25,409
-17,385
-26,958
Normalized Income
-29,764
-33,776
-26,359
-16,927
-26,465
Interest Income
294.906
148.556
12.55
-
-
Interest Expense
10.696
24.047
32.33
7.686
128.951
Net Interest Income
284.21
124.509
-19.78
-7.686
-128.951
EBIT
-30,406
-33,752
-25,377
-17,377
-26,829
EBITDA
-29,006
-
-
-
-
Reconciled Depreciation
1,400
1,263
403.043
280.463
128.372
Net Income from Continuing Operation Net Minority Interest
-30,417
-33,776
-25,409
-17,385
-26,958
Total Unusual Items Excluding Goodwill
-652.451
-
950.151
-457.038
-492.889
Total Unusual Items
-652.451
-
950.151
-457.038
-492.889
Normalized EBITDA
-28,354
-32,490
-25,924
-16,920
-26,208
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0

Yahoo Finance Plus Essential access required.

Learn more